Skip to main content
Clinical Trials/JPRN-UMIN000039949
JPRN-UMIN000039949
Completed
未知

The effect of community pharmacist intervention on dementia patients on care burden-development of an intervention protocol and feasibility study - COMPREHEND study(1)(Feasibility study on the effect of community pharmacist on intervention for dementia patients)

Osaka University of Pharmaceutical Sciences0 sites19 target enrollmentApril 1, 2020
ConditionsDementia

Overview

Phase
未知
Intervention
Not specified
Conditions
Dementia
Sponsor
Osaka University of Pharmaceutical Sciences
Enrollment
19
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 1, 2020
End Date
May 31, 2019
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\) Patients receiving home care services by pharmacists (2\) Those who cannot obtain the consent to participate in the research from the patient or the substitute

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
Effect of community pharmacists led intervention using a smartphone app (PharmQuit) on smoking cessatioHigh loss follow upPharmQuitSmartphone appSmoking cessationCommunity pharmacistThailandAppPhone app
TCTR20200925004ational Health Security Office Region 7 Khon Kaen156
Completed
Not Applicable
Evaluation of the use of a patient questionnaire in measuring patient reported outcomes of medication reviewsadverse drug reactions (ADRs), side effects of drugs, medication adherence (MARS), beliefs about medicines necessity and concerns (BMQ), self efficacy (MUSE)
NL-OMON28732Radboud university medical center, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen, The Netherlands200
Completed
Not Applicable
Community Pharmacy promoting appropriate sedative use in Aged Care: the RedUSeprojectSedative use in residential aged care facilities. Sedatives are classified for the purposes of this study as antipsychotic, anxiolytic and hypnotic drugs. The majority of anxiolytic and hypnotic dugs are benzodiazepines.Mental Health - Other mental health disordersPublic Health - Health promotion/education
ACTRN12608000221358The Pharmacy Guild of Australia24
Unknown
Not Applicable
Impact of Pharmaceutical Care by Community Pharmacist on Type 2 Diabetes Outcomes: A Cluster Randomized Controlled Study
PACTR201903495704553namdi Azikiwe University90
Recruiting
Not Applicable
Impact of clinical pharmacist interventions on the clinical outcome of patients with Bipolar Disorder (BD)
IRCT20210307050613N1Tehran University of Medical Sciences112